Wu, Y., Fan, Y., Dong, D., Dong, X., Hu, Y., Shi, Y., . . . Li, E. (2020). Efficacy and safety of regorafenib as beyond second-line therapy in patients with metastatic colorectal cancer: An adjusted indirect meta-analysis and systematic review. Ther Adv Med Oncol.

Wu, Yinying, Yangwei Fan, Danfeng Dong, Xuyuan Dong, Yuan Hu, Yu Shi, Jiayu Jing, and Enxiao Li. "Efficacy and Safety of Regorafenib As Beyond Second-line Therapy in Patients With Metastatic Colorectal Cancer: An Adjusted Indirect Meta-analysis and Systematic Review." Ther Adv Med Oncol 2020.

Wu, Yinying, et al. "Efficacy and Safety of Regorafenib As Beyond Second-line Therapy in Patients With Metastatic Colorectal Cancer: An Adjusted Indirect Meta-analysis and Systematic Review." Ther Adv Med Oncol 2020.